No Vote, No Mandate? FDA Opioid Meeting Shows Limits Of Non-Voting Panels

 
• By Michael McCaughan
  
FDA no voting
Is this the best direction for FDA? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from US FDA Performance Tracker

More from Regulatory Trackers